Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2021

Oct 5, 2021

30870_dirs_2021-10-04_62f705b7-56ad-49af-9a45-3e1a47f4006b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-10-01

Reporting Person: Kaye Edward M. MD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-01 Common Stock A 306 $36.74 Acquired 6765 Direct

Footnotes

F1: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $36.74, representing the Issuer's closing stock price on October 1, 2021.

F2: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.